Jakob Izbicki
Prof. Dr. med. Prof. h.c. Dr. h.c.
Jakob R. Izbicki
FACS FRCS ed. hon.
  • Director of Center
  • Director of the department
  • Medical Specialist in Visceral Surgery
  • Medical Specialist in Thoracic Surgery
  • Medical Specialist in General Surgery
  • Special Visceral Surgery
Working area

Location

Main Building O10 , 2nd Floor
Languages
German (Mother tongue)

Areas of expertise

Awards

Memberships

Publications

Zurück
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2003
Vor

Aberrant expression of Sec61α in esophageal cancers
Bachmann K, Bockhorn M, Mann O, Gebauer F, Blessmann M, Izbicki J, Grupp K
J CANCER RES CLIN. 2019;145(8):2039-2044.

Morphologic Factors Predict Pain Relief Following Pancreatic Head Resection in Chronic Pancreatitis Description of the Chronic Pancreatitis Pain Relief (CPPR) Score
Bachmann K, Melling N, Groteluschen R, Fleischauer A, Reeh M, Ghadban T, Bockhorn M, Izbicki J
ANN SURG. 2019 [Epub ahead of print].

Duodenum-preserving pancreatic head resection: A retrospective analysis of the Hamburg Modification
Bellon E, Roswora M, Melling N, Grotelueschen R, Grupp K, Reeh M, Ghadban T, Izbicki J, Bachmann K
SURGERY. 2019;165(5):938-945.

Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer
Blessin N, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin N, Höflmayer D, Lennartz M, Sauter G, Izbicki J, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke A, Wittmer C, Jacobsen F, Burandt E, Steurer S, Wilczak W, Hinsch A
DIS MARKERS. 2019;2019:5160565.

Fluoreszenzangiographie bei Ösophagusanastomosen: Perfusionsbeurteilung des Magenschlauchs mit Indocyaningrün
Duprée A, von Kroge P, Izbicki J, Wipper S, Mann O
CHIRURG. 2019 [Epub ahead of print].

High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients
El Gammal A, Melling N, Reeh M, Gebauer F, Mann O, Perez D, Bockhorn M, Bachmann K, Izbicki J, Grupp K
EXP MOL PATHOL. 2019;107:51-56.

Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality
Ghadban T, Reeh M, Bockhorn M, Grotelueschen R, Bachmann K, Grupp K, Uzunoglu F, Izbicki J, Perez D
CANCER MANAG RES. 2019;11:2101-2107.

Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery
Grass J, Perez D, Izbicki J, Reeh M
EJSO-EUR J SURG ONC. 2019;45(4):498-509.

Microbial findings, sensitivity and outcome in patients with postoperative peritonitis a retrospective cohort study
Grotelueschen R, Luetgehetmann M, Erbes J, Heidelmann L, Grupp K, Karstens K, Ghadban T, Reeh M, Izbicki J, Bachmann K
INT J SURG. 2019;70:63-69.

Cholecystokinin-8 treatment reduces acinar necrosis and edema of pigs with induced pancreatitis
Grupp K, Bonk S, Poppe A, Wodack K, Reeh M, Gocht A, Mann O, Izbicki J, Bachmann K
ASIAN J SURG. 2019 [Epub ahead of print].

Melatonin treatment of pigs with acute pancreatitis reduces inflammatory reaction of pancreatic tissue and enhances fitness score of pigs: experimental research
Grupp K, Erbes J, Poppe A, Wodack K, Gocht A, Trepte C, Havel J, Mann O, Izbicki J, Bachmann K
WORLD J EMERG SURG. 2019;14:18.

Expression of the immune checkpoint receptor TIGIT in seminoma
Hinsch A, Blessin N, Simon R, Kluth M, Fischer K, Hube-Magg C, Li W, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin N, Höflmayer D, Lennartz M, Sauter G, Izbicki J, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke A, Wittmer C, Jacobsen F, Burandt E, Steurer S, Wilczak W
ONCOL LETT. 2019;18(2):1497-1502.

Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC)
Hötzel J, Melling N, Müller J, Polonski A, Wolters-Eisfeld G, Izbicki J, Karstens K, Tachezy M
J CANCER RES CLIN. 2019;145(9):2285-2292.

Clinical outcome of patients undergoing abdominoplasty after massive weight loss
Hunecke P, Toll M, Mann O, Izbicki J, Blessmann M, Grupp K
SURG OBES RELAT DIS. 2019;15(8):1362-1366.

Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer
Kemper M, Strohm T, Grupp K, Ghadban T, Bogoevski D, Bachmann K, Bockhorn M, Sauter G, Izbicki J, Reeh M
ANTICANCER RES. 2019;39(3):1191-1196.

Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer
Konczalla L, Ghadban T, Effenberger K, Wöstemeier A, Riethdorf S, Uzunoglu F, Izbicki J, Pantel K, Bockhorn M, Reeh M
ANN SURG. 2019.

Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer
Konczalla L, Perez D, Wenzel N, Wolters-Eisfeld G, Klemp C, Lüddeke J, Wolski A, Landschulze D, Meier C, Buchholz A, Yao D, Hofmann B, Graß J, Spriestersbach S, Grupp K, Schumacher U, Betzel C, Kapis S, Nuguid T, Steinberg P, Püschel K, Sauter G, Bockhorn M, Uzunoglu F, Izbicki J, Güngör C, El Gammal A
INT J CANCER. 2019 [Epub ahead of print].

Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder
Mandelkow T, Blessin N, Lueerss E, Pott L, Simon R, Li W, Wellge B, Debatin N, Höflmayer D, Izbicki J, Büscheck F, Luebke A, Wittmer C, Jacobsen F, Lutz F, Burandt E, Steurer S, Sauter G, Tsourlakis M, Wilczak W, Hinsch A, Minner S
DIS MARKERS. 2019;2019:2532518.

Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers
Melling N, Bachmann K, Hofmann B, El Gammal A, Reeh M, Mann O, Moebius C, Blessmann M, Izbicki J, Grupp K
J CANCER RES CLIN. 2019;145(4):873-879.

Robotic cholecystectomy: first experience with the new Senhance robotic system
Melling N, Barr J, Schmitz R, Polonski A, Miro J, Ghadban T, Wodack K, Izbicki J, Zani S, Perez D
J Robot Surg. 2019;13(3):495-500.

p53 overexpression is a prognosticator of poor outcome in esophageal cancer
Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F
ONCOL LETT. 2019;17(4):3826-3834.

Standardisierte Zugangsoptionen für die kolorektale Chirurgie mit dem Da-Vinci-Xi-System
Perez D, Woestemeier A, Ghadban T, Stein H, Gomez-Ruiz M, Izbicki J, Soh Min B
CHIRURG. 2019.

Pancreatitis due to pancreatic metastases of small bowel and lung neuroendocrine tumors
Reher D, Henes F, Clauditz T, Klutmann S, Izbicki J, Lohse A, Perez D, Schrader J
2019. ENETS Conference Programm. 73.

Successful Use of the Recanalized Remnant Umbilical Vein as a Patch Graft for Venous Reconstruction in Abdominal Surgery
Stüben B, Heumann A, Stürznickel J, Izbicki J, Li J
J GASTROINTEST SURG. 2019;23(6):1227-1231.

Oligometastases in pancreatic cancer (Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis)
Voss N, Izbicki J, Nentwich M
Annals of gastroenterological surgery. 2019;3(4):373-377.

Mentorship Programs in Bariatric Surgery Reduce Perioperative Complication Rate at Equal Short-Term Outcome-Results from the OPTIMIZE Trial
Wolter S, Duprée A, ElGammal A, Runkel N, Heimbucher J, Izbicki J, Mann O, Busch P
OBES SURG. 2019;29(1):127-136.

Lower Gastrointestinal Surgery: Robotic Surgery versus Laparoscopic Procedures
Baukloh J, Perez D, Reeh M, Biebl M, Izbicki J, Pratschke J, Aigner F
Visc Med. 2018;34(1):16-22.

Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl F, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki J, Lohse A, Schrader J
MOL CANCER RES. 2018;16(3):496-507.

Molecular and functional heterogeneity of IL-10-producing CD4+ T cells
Brockmann L, Soukou S, Steglich B, Czarnewski P, Zhao L, Wende S, Bedke T, Ergen C, Manthey C, Agalioti T, Geffken M, Seiz O, Parigi S, Sorini C, Geginat J, Fujio K, Jacobs T, Roesch T, Izbicki J, Lohse A, Flavell R, Krebs C, Gustafsson J, Antonson P, Roncarolo M, Villablanca E, Gagliani N, Huber S
NAT COMMUN. 2018;9(1):5457.

CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target
Drenckhan A, Freytag M, Supuran C, Sauter G, Izbicki J, Gros S
J ENZYM INHIB MED CH. 2018;33(1):1024-1033.

Improved risk stratification by circulating tumor cell counts in pancreatic cancer
Effenberger K, Schroeder C, Hanssen A, Wolter S, Eulenburg C, Tachezy M, Gebauer F, Izbicki J, Pantel K, Bockhorn M
CLIN CANCER RES. 2018;24(12):2844-2850.

Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management
El Gammal A, Izbicki J
SURG CLIN N AM. 2018;98(1):141-155.

Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade
Ghadban T, Reeh M, Bockhorn M, Heumann A, Grotelueschen R, Bachmann K, Izbicki J, Perez D
SCI REP-UK. 2018;8(1):15146.

Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome
Grupp K, Hofmann B, Kutup A, Bachmann K, Bogoevski D, Melling N, Uzunoglu F, El Gammal A, Koop C, Simon R, Steurer S, Krech T, Burdak-Rothkamm S, Jacobsen F, Sauter G, Izbicki J, Wilczak W
BMC CANCER. 2018;18(1):1106.

FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas
Grupp K, Uzunoglu F, Melling N, Hofmann B, El Gammal A, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki J, Kutup A
SCI REP-UK. 2018;8(1):17370.

Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang D, Simon R, Beyer B, Thederan I, Sauter G, Izbicki J, Luebke A, Hinsch A, Jacobsen F, Wittmer C, Büscheck F, Höflmayer D, Minner S, Tsourlakis M, Schlomm T, Wilczak W
SCI REP-UK. 2018;8(1):12821.

High expression of class III β-tubulin in upper gastrointestinal cancer types
Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin N, Simon R, Lang D, Neubauer E, Göbel C, Heinrich M, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, Lühr C, Noack M, Reiswich V, Weidemann S, Bockhorn M, Perez D, Izbicki J, Sauter G, Jacobsen F
ONCOL LETT. 2018;16(6):7139-7145.

Syndecan-1 as a biomarker for sepsis survival after major abdominal surgery
Holzmann M, Winkler M, Strunden M, Izbicki J, Schoen G, Greiwe G, Pinnschmidt H, Poppe A, Saugel B, Daum G, Goetz A, Heckel K
BIOMARK MED. 2018;12(2):119-127.

Does the Margin Matter in Esophageal Cancer?
Karstens K, Izbicki J, Reeh M
DIGEST SURG. 2018;35(3):196-203.

Surgical Treatment of Chronic Pancreatitis: The State of the Art
Kemper M, Izbicki J, Bachmann K
CHIRURGIA-BUCHAREST. 2018;113(3):300-306.

Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma
Li W, Blessin N, Simon R, Kluth M, Fischer K, Hube-Magg C, Makrypidi-Fraune G, Wellge B, Mandelkow T, Debatin N, Pott L, Höflmayer D, Lennartz M, Sauter G, Izbicki J, Minner S, Büscheck F, Uhlig R, Dum D, Krech T, Luebke A, Wittmer C, Jacobsen F, Burandt E, Steurer S, Wilczak W, Hinsch A
BMC CANCER. 2018;18(1):1209.

EXPRESSION OF TN ANTIGEN PROMOTES PANCREATIC CARCINOGENESIS IN A TRANSGENIC MOUSE MODEL
Mercanoglu B, Wolters-Eisfeld G, Güngör C, Izbicki J, Bockhorn M
UNITED EUR GASTROENT. 2018.

Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: A comparison of 115 cases
Perez D, Melling N, Biebl M, Reeh M, Baukloh J, Miro J, Polonski A, Izbicki J, Knoll B, Pratschke J, Aigner F
EJSO-EUR J SURG ONC. 2018;44(2):237-242.

Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer
Woestemeier A, Ghadban T, Riethdorf S, Harms-Effenberger K, Konczalla L, Uzunoglu F, Izbicki J, Pantel K, Bockhorn M, Reeh M
ANTICANCER RES. 2018;38(10):5665-5669.

Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice.
Wolters-Eisfeld G, Mercanoglu B, Hofmann B, Wolpers T, Schnabel C, Harder S, Steffen P, Bachmann K, Steglich B, Schrader J, Gagliani N, Schlüter H, Güngör C, Izbicki J, Wagener C, Bockhorn M
EXP MOL MED. 2018;50(10):133.

Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice
Wolters-Eisfeld G, Mercanoglu B, Hofmann B, Wolpers T, Schnabel C, Harder S, Steffen P, Bachmann K, Steglich B, Schrader J, Gagliani N, Schlüter H, Güngör C, Izbicki J, Wagener C, Bockhorn M
EXP MOL MED. 2018;50(10):.

Evaluation of the robotic approach concerning pitfalls in rectal surgery
Baukloh J, Reeh M, Spinoglio G, Corratti A, Bartolini I, Mirasolo V, Priora F, Izbicki J, Gomez Fleitas M, Gomez Ruiz M, Perez D
EJSO-EUR J SURG ONC. 2017;43(7):1304-1311.

Pankreasanastomosen bei operativer Versorgung der chronischen Pankreatitis
Bellon E, Izbicki J, Bockhorn M
CHIRURG. 2017;88(1):18-24.

HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer
Bogoevska V, Wolters-Eisfeld G, Hofmann B, El Gammal A, Mercanoglu B, Gebauer F, Vashist Y, Bogoevski D, Perez D, Gagliani N, Izbicki J, Bockhorn M, Güngör C
ONCOGENE. 2017;36(17):2394-2404.

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
Burdelski C, Borcherding L, Kluth M, Hube-Magg C, Melling N, Simon R, Möller-Koop C, Weigand P, Minner S, Haese A, Michl H, Tsourlakis M, Jacobsen F, Hinsch A, Wittmer C, Lebok P, Steurer S, Izbicki J, Sauter G, Krech T, Büscheck F, Clauditz T, Schlomm T, Wilczak W
ONCOTARGET. 2017;8(19):31494-31508.

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers
Burdelski C, Fitzner M, Hube-Magg C, Kluth M, Heumann A, Simon R, Krech T, Clauditz T, Büscheck F, Steurer S, Wittmer C, Hinsch A, Luebke A, Jacobsen F, Minner S, Tsourlakis M, Beyer B, Steuber T, Thederan I, Sauter G, Izbicki J, Schlomm T, Wilczak W
NEOPLASIA. 2017;19(4):279-287.

Pankreatikoduodenektomie
El Gammal A, Perez D, Izbicki J
2017. Expertise Pankreas. Izbicki J, Perez D (eds.). 1. ed. Georg Thieme Verlag KG, 27-33.

Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases
El Gammal A, Sturm J, Pinnschmidt H, Hofmann B, Bellon E, Ghadban T, Melling N, Bachmann K, Izbicki J, Bockhorn M, Güngör C, Perez D
Int J Clin Endocrinol Metab. 2017;3(1):023-028.

HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer
Ghadban T, Dibbern J, Reeh M, Miro J, Tsui T, Wellner U, Izbicki J, Güngör C, Vashist Y
APOPTOSIS. 2017;22(3):369-380.

TRYPTOPHAN DEGRADATION AS AN ALTERNATIVE ENERGY SOURCE IN PANCREATIC CANCER
Güngör C, Mercanoglu B, Wolters-Eisfeld G, Izbicki J, Bockhorn M
UNITED EUR GASTROENT. 2017;5: Supplement 1.

Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Heumann A, Kaya Ö, Burdelski C, Hube-Magg C, Kluth M, Lang D, Simon R, Beyer B, Thederan I, Sauter G, Izbicki J, Luebke A, Hinsch A, Jacobsen F, Wittmer C, Büscheck F, Höflmayer D, Minner S, Tsourlakis M, Schlomm T, Wilczak W
SCI REP-UK. 2017;7(1):2056.

Erweiterte Pankreasresektion
Heumann A, Perez D, Izbicki J
2017. Expertise Pankreas. Izbicki J, Perez D (eds.). 1. ed. Georg Thieme Verlag KG, 44-51.

MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays
Hinsch A, Buchholz M, Odinga S, Borkowski C, Koop C, Izbicki J, Wurlitzer M, Krech T, Wilczak W, Steurer S, Jacobsen F, Burandt E, Stahl P, Simon R, Sauter G, Schlüter H
J MASS SPECTROM. 2017;52(3):165-173.

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
Jacobsen F, Kraft J, Schroeder C, Hube-Magg C, Kluth M, Lang D, Simon R, Sauter G, Izbicki J, Clauditz T, Luebke A, Hinsch A, Wilczak W, Wittmer C, Büscheck F, Höflmayer D, Minner S, Tsourlakis M, Huland H, Graefen M, Budäus L, Thederan I, Salomon G, Schlomm T, Melling N
NEOPLASIA. 2017;19(9):707-715.

Duodenumerhaltende Pankreaskopfresektion
Meiners J, Perez D, Izbicki J, Uzunoglu F
2017. Expertise Pankreas. Izbicki J, Perez D (eds.). 1. ed. Georg Thieme Verlag KG, 98-102.

HYPOXIA INDUCED HIF1A-MEDIATED DIFFERENTIAL O-GALNAC GLYCOSYLATION DIRECTLY REGULATES SIGNALING PATHWAYS IN PANCREATIC CANCER
Mercanoglu B, Hofmann B, Güngör C, Izbicki J, Bockhorn M, Wolters-Eisfeld G
UNITED EUR GASTROENT. 2017.

Expression of Tn Antigen Causes Chronic Pancreatitis in a Transgenic Mouse Model
Mercanoglu B, Karstens K, Güngör C, Izbicki J, Bockhorn M, Wolters-Eisfeld G
European Surgical Research. 2017.

EXPRESSION OF TN ANTIGEN CAUSES CHRONIC PANCREATITIS IN A TRANSGENIC MOUSE MODEL
Mercanoglu B, Karstens K, Güngör C, Izbicki J, Bockhorn M, Wolters-Eisfeld G
UNITED EUR GASTROENT. 2017.

Die Expression des Tn Antigens begünstigt die pankreatische Karzinogenese in einem transgenen Mausmodell
Mercanoglu B, Wolters-Eisfeld G, Güngör C, Izbicki J, Bockhorn M
Z GASTROENTEROL. 2017.

DIFFERENTIALLY O-GLYCOSYLATED CARBOXYL ESTER LIPASE CAUSES A MODY8-LIKE PHENOTYPE IN MICE
Mercanoglu B, Wolters-Eisfeld G, Güngör C, Izbicki J, Bockhorn M
UNITED EUR GASTROENT. 2017.

Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours
Mills L, Drymousis P, Vashist Y, Burdelski C, Prachalias A, Srinivasan P, Menon K, Cotoi C, Khan S, Cave J, Armstrong T, Weickert M, Izbicki J, Schrader J, Frilling A, Ramage J, Srirajaskanthan R
ENDOCR CONNECT. 2017;6(8):876-885.

Totale Pankreatektomie
Nentwich M, Bockhorn M, Izbicki J
2017. Expertise Pankreas. Izbicki J, Perez D (eds.). 1. ed. Georg Thieme Verlag KG, 78-82.

Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs)
Nentwich M, Menzel K, Reeh M, Uzunoglu F, Ghadban T, Bachmann K, Schrader J, Bockhorn M, Izbicki J, Perez D
EJSO-EUR J SURG ONC. 2017;43(4):758-762.

Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer
Reeh M, Ghadban T, Dedow J, Vettorazzi E, Uzunoglu F, Nentwich M, Kluge S, Izbicki J, Vashist Y
WORLD J SURG. 2017;41(1):208-215.

Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
Reeh M, Ghadban T, Uzunoglu F, Nentwich M, Bockhorn M, Pantel K, Izbicki J, Vashist Y
BRIT J CANCER. 2017;117(5):612-618.

Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation
Schrader J, Henes F, Perez D, Burdak-Rothkamm S, Stein A, Izbicki J, Lohse A
ANN ONCOL. 2017;28(4):904-905.

Synergistische Therapiewirkung der Kombination des Hsp90 Inhibitor AUY922 und des PI3K Inhibitors BYL719 mit Everolimus bei neuroendokrinen Tumoren
Weißmann V, Benten D, Wolters-Eisfeld G, Perez D, Izbicki J, Lohse A, Schrader J
Z GASTROENTEROL. 2017;55(08):KV 402.

Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer
Wilczak W, Rashed S, Hube-Magg C, Kluth M, Simon R, Büscheck F, Clauditz T, Grupp K, Minner S, Tsourlakis M, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Sauter G, Izbicki J, Huland H, Schlomm T, Steurer S, Krech T, Lebok P
CARCINOGENESIS. 2017;38(1):19-27.

Upper Gastrointestinal Endoscopy prior to Bariatric Surgery-Mandatory or Expendable? An Analysis of 801 Cases
Wolter S, Duprée A, Miro J, Schroeder C, Jansen M, Schulze-Zur-Wiesch C, Groth S, Izbicki J, Mann O, Busch P
OBES SURG. 2017;27(8):1938-1943.

Hypoxia induced HIF1a-mediated O-GalNAc glycosylation of cytosolic O-GlcNAcylated proteins to regulate signaling pathways in pancreatic cancer.
Wolters-Eisfeld G, Mercanoglu B, Güngör C, Izbicki J, Bockhorn M
J CLIN ONCOL. 2017;35(15_suppl):e15739-e15739.

Duodenal Electric Stimulation: Results of a First-in-Man Study
Aberle J, Busch C, Veigel J, Duprée A, Roesch T, Zu Eulenburg C, Paschen B, Scholz B, Wolter S, Sauer N, Ludwig K, Izbicki J, Mann O
OBES SURG. 2016;26(2):369-75.

Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma
Ameis H, Drenckhan A, Freytag M, Izbicki J, Supuran C, Reinshagen K, Holland-Cunz S, Gros S
J ENZYM INHIB MED CH. 2016;31(3):404-9.

Influence of hypoxia-dependent factors on the progression of neuroblastoma
Ameis H, Drenckhan A, Freytag M, Izbicki J, Supuran C, Reinshagen K, Holland-Cunz S, Gros S
PEDIATR SURG INT. 2016;32(2):187-92.

Wie bewerkstelligt robotische Chirurgie die Fallstricke der Rektumchirurgie? Eine europäische multizentrische Evaluation
Baukloh J, Reeh M, Spinoglio G, Coratti A, Mirasolo V, Bartolini I, Priora F, Hiller J, Kollbeck S, Izbicki J, Gomez Fleitas M, Gomez Ruiz M, Perez D
Z GASTROENTEROL. 2016.

The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk
Becker J, May A, Gerges C, Anders M, Schmidt C, Veits L, Noder T, Mayershofer R, Kreuser N, Manner H, Venerito M, Hofer J, Lyros O, Ahlbrand C, Arras M, Hofer S, Heinrichs S, Weise K, Hess T, Böhmer A, Kosiol N, Kiesslich R, Izbicki J, Hölscher A, Bollschweiler E, Malfertheiner P, Lang H, Moehler M, Lorenz D, Ott K, Schmidt T, Nöthen M, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismüller J, Knapp M, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J
CANCER MED-US. 2016;5(5):888-91.

Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery
Besselink M, van Rijssen L, Bassi C, Dervenis C, Montorsi M, Adham M, Asbun H, Bockhorn M, Strobel O, Büchler M, Busch O, Charnley R, Conlon K, Fernández-Cruz L, Fingerhut A, Friess H, Izbicki J, Lillemoe K, Neoptolemos J, Sarr M, Shrikhande S, Sitarz R, Vollmer C, Yeo C, Hartwig W, Wolfgang C, Gouma D
SURGERY. 2016;161(2):365-372.

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer
Burdelski C, Dieckmann T, Heumann A, Hube-Magg C, Kluth M, Beyer B, Steuber T, Pompe R, Graefen M, Simon R, Minner S, Tsourlakis M, Koop C, Izbicki J, Sauter G, Krech T, Schlomm T, Wilczak W, Lebok P
TUMOR BIOL. 2016;37(9):12655-12663.

Endoscopic ultrasound-guided drainage of abdominal fluid collections after pancreatic surgery: Efficacy and long-term follow-up
Denzer U, Sioulas A, Abdulkarim M, Groth S, Rösch T, Busch C, Izbicki J, Ittrich H, Adam G, Schachschal G
Z GASTROENTEROL. 2016;54(9):1047-53.

Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
Gebauer F, Gelis S, Zander H, Meyer K, Wolters-Eisfeld G, Izbicki J, Bockhorn M, Tachezy M
ONCOTARGET. 2016;7(15):20945-52.

Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis
Gebauer F, Wicklein D, Tachezy M, Grob T, Steinemann D, Manukjan G, Göhring G, Schlegelberger B, Maar H, Izbicki J, Bockhorn M, Schumacher U
ANTICANCER RES. 2016;36(4):1507-18.

In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines
Ghadban T, Jessen A, Reeh M, Dibbern J, Mahner S, Mueller V, Wellner U, Güngör C, Izbicki J, Vashist Y
INT J MOL MED. 2016;38(4):1296-302.

Diverse prognostic value of the GTn promoter polymorphism in squamous cell and adeno carcinoma of the esophageus
Ghadban T, Miro J, Trump F, Tsui T, Uzunoglu F, Reeh M, Gebauer F, Bachmann K, Wellner U, Kalinin V, Pantel K, Izbicki J, Vashist Y
CLIN GENET. 2016;90(4):343-50.

Prognostic Significant or Not? The Positive Circumferential Resection Margin in Esophageal Cancer: Impact on Local Recurrence and Overall Survival in Patients Without Neoadjuvant Treatment
Ghadban T, Reeh M, Koenig A, Nentwich M, Bellon E, Izbicki J, Vashist Y, Kutup A
ANN SURG. 2016;266(6):988-994.

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
Gharahkhani P, Fitzgerald R, Vaughan T, Palles C, Gockel I, Tomlinson I, Buas M, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer A, Izbicki J, Hölscher A, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen M, Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love S, MacDonald D, Moayyedi P, Prenen H, Watson R, Iyer P, Anderson L, Bernstein L, Chow W, Hardie L, Lagergren J, Liu G, Risch H, Wu A, Ye W, Bird N, Shaheen N, Gammon M, Corley D, Caldas C, Moebus S, Knapp M, Peters W, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman D, Jankowski J, Schumacher J
LANCET ONCOL. 2016;17(10):1363-1373.

Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer.
Hofmann B, Kwiatkowski M, Izbicki J, Bockhorn M, Güngör C, Ewald F, Wolters-Eisfeld G
J CLIN ONCOL. 2016;34(15_suppl):e15673-e15673.

Pancreatic surgery
Izbicki J, Montorsi M
Updates Surg. 2016;68(3):215.

The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus
Kilic E, Tennstedt P, Högner A, Lebok P, Sauter G, Bokemeyer C, Izbicki J, Wilczak W
VIRCHOWS ARCH. 2016;468(4):483-92.

Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment
Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu F, Vashist Y, Izbicki J, Bogoevski D
SURGERY. 2016;159(6):1548-56.

High Ki67 expression is an independent good prognostic marker in colorectal cancer
Melling N, Kowitz C, Simon R, Bokemeyer C, Terracciano L, Sauter G, Izbicki J, Marx A
J CLIN PATHOL. 2016;69(3):209-14.

Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer
Melling N, Taskin B, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Heinzer H, Tsourlakis M, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, Sauter G, Steurer S, Schlomm T, Krech T
PROSTATE. 2016;76(3):259-72.

Non-trauma Emergency Pancreatoduodenectomies: A Single-Center Retrospective Analysis
Nentwich M, Reeh M, Uzunoglu F, Bachmann K, Bockhorn M, Izbicki J, Vashist Y
WORLD J SURG. 2016;40(9):2261-6.

A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease
Pelczar P, Witkowski M, Perez L, Kempski J, Hammel A, Brockmann L, Kleinschmidt D, Wende S, Haueis C, Bedke T, Krasemann S, Steurer S, Booth C, Busch C, König A, Rauch U, Benten D, Izbicki J, Rösch T, Lohse A, Strowig T, Gagliani N, Flavell R, Huber S
SCIENCE. 2016;354(6310):358-362.

Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence
Pust A, Kylies D, Hube-Magg C, Kluth M, Minner S, Koop C, Grob T, Graefen M, Salomon G, Tsourlakis M, Izbicki J, Wittmer C, Huland H, Simon R, Wilczak W, Sauter G, Steurer S, Krech T, Schlomm T, Melling N
HUM PATHOL. 2016;48:102-10.

The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer
Reeh M, Metze J, Uzunoglu F, Nentwich M, Ghadban T, Wellner U, Bockhorn M, Kluge S, Izbicki J, Vashist Y
MEDICINE. 2016;95(7):e2724.

Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer
Schirmer M, Lüske C, Roppel S, Schaudinn A, Zimmer C, Pflüger R, Haubrock M, Rapp J, Güngör C, Bockhorn M, Hackert T, Hank T, Strobel O, Werner J, Izbicki J, Johnsen S, Gaedcke J, Brockmöller J, Ghadimi B
JNCI-J NATL CANCER I. 2016;108(5):djv387.

Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis
Tachezy M, Gebauer F, Janot M, Uhl W, Zerbi A, Montorsi M, Perinel J, Adham M, Dervenis C, Agalianos C, Malleo G, Maggino L, Stein A, Izbicki J, Bockhorn M
SURGERY. 2016;160(1):136-44.

The Effects of Pancreatic Microcirculatory Disturbances on Histopathologic Tissue Damage and the Outcome in Severe Acute Pancreatitis
Tomkötter L, Erbes P, Trepte C, Hinsch A, Dupree A, Bockhorn M, Mann O, Izbicki J, Bachmann K
PANCREAS. 2016;45(2):248-253.

How we do it: double in situ split for staged mesohepatectomy in patients with advanced gall bladder cancer and marginal future liver remnant
Tsui T, Heumann A, Vashist Y, Izbicki J
LANGENBECK ARCH SURG. 2016;401(4):565-71.

Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma
Wachowiak R, Mayer S, Kaifi J, Gebauer F, Izbicki J, Lacher M, Bockhorn M, Tachezy M
ANTICANCER RES. 2016;36(8):3991-5.

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry
Bachmann K, Neumann A, Hinsch A, Nentwich M, El Gammal A, Vashist Y, Perez D, Bockhorn M, Izbicki J, Mann O
J SURG ONCOL. 2015;111(3):316-23.

Roboter assistierte versus offene Chirurgie bei tiefem Rektumkarzinom - Initiale Erfahrung in Hamburg-Eppendorf
Baukloh J, Reeh M, Bockhorn M, Hiller J, Izbicki J, Perez D
2015. 195. Sommertagung der Vereinigung Norddeutscher Chirurgen. .

Roboter-assistierte versus offene tiefe anteriore Rektumresektion – Initiale Erfahrung im Hamburg-Eppendorf
Baukloh J, Reeh M, Bockhorn M, Izbicki J, Perez D
Z GASTROENTEROL. 2015.

Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma
Becker J, May A, Gerges C, Anders M, Veits L, Weise K, Czamara D, Lyros O, Manner H, Terheggen G, Venerito M, Noder T, Mayershofer R, Hofer J, Karch H, Ahlbrand C, Arras M, Hofer S, Mangold E, Heilmann-Heimbach S, Heinrichs S, Hess T, Kiesslich R, Izbicki J, Hölscher A, Bollschweiler E, Malfertheiner P, Lang H, Moehler M, Lorenz D, Müller-Myhsok B, Ott K, Schmidt T, Whiteman D, Vaughan T, Nöthen M, Hackelsberger A, Schumacher B, Pech O, Vashist Y, Vieth M, Weismüller J, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J
CANCER RES. 2015;4(11):1700-4.

HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer
Burdelski C, Ruge O, Melling N, Koop C, Simon R, Steurer S, Sauter G, Kluth M, Hube-Magg C, Minner S, Wittmer C, Wilczak W, Hinsch A, Lebok P, Izbicki J, Heinzer H, Graefen M, Huland H, Schlomm T, Krech T
EXP MOL PATHOL. 2015;98(3):419-426.

Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
Gebauer F, Tachezy M, Vashist Y, Marx A, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(2):493-9.

Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, El Gammal A, Miro J, Wellner U, Pantel K, Izbicki J, Vashist Y
CANCER GENET-NY. 2015;208(12):595–601.

Correction to: An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2015;60(2):107.

High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer
Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P, Terracciano L, Izbicki J, Marx A
AM J CLIN PATHOL. 2015;8(7):8227-35.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
Hofmann B, Schlüter L, Lange P, Mercanoglu B, Ewald F, Fölster A, Picksak A, Harder S, El Gammal A, Grupp K, Güngör C, Drenckhan A, Schlüter H, Wagener C, Izbicki J, Jücker M, Bockhorn M, Wolters-Eisfeld G
MOL CANCER. 2015;14(1):109.

Fighting for Academic Surgical Oncology: Where Do We Come From, Where Are We Now, and Where Should We Head?
Izbicki J
ANN SURG. 2015;262(5):701-3.

ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts
Kebenko M, Drenckhan A, Gros S, Jücker M, Grabinski N, Ewald F, Grottke A, Schultze A, Izbicki J, Bokemeyer C, Wellbrock J, Fiedler W
CELL SIGNAL. 2015;27(2):373-81.

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial
Keck T, Wellner U, Bahra M, Klein F, Sick O, Niedergethmann M, Wilhelm T, Farkas S, Börner T, Bruns C, Kleespies A, Kleeff J, Mihaljevic A, Uhl W, Chromik A, Fendrich V, Heeger K, Padberg W, Hecker A, Neumann U, Junge K, Kalff J, Glowka T, Werner J, Knebel P, Piso P, Mayr M, Izbicki J, Vashist Y, Bronsert P, Bruckner T, Limprecht R, Diener M, Rossion I, Wegener I, Hopt U
ANN SURG. 2015;263(3):440-9.

Drosophila homologue of Diaphanous 1 (DIAPH1) controls the metastatic potential of colon cancer cells by regulating microtubule-dependent adhesion
Lin Y, Bhuwania R, Gromova K, Failla A, Lange T, Riecken K, Linder S, Kneussel M, Izbicki J, Windhorst S
ONCOTARGET. 2015;6(21):18577-89.

Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers
Melling N, Grimm N, Simon R, Stahl P, Bokemeyer C, Terracciano L, Sauter G, Izbicki J, Marx A
PATHOL ONCOL RES. 2015;22(1):95-102.

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
Melling N, Harutyunyan L, Hube-Magg C, Kluth M, Simon R, Lebok P, Minner S, Tsourlakis M, Koop C, Graefen M, Adam M, Haese A, Wittmer C, Steurer S, Izbicki J, Sauter G, Wilczak W, Schlomm T, Krech T
PLOS ONE. 2015;10(7):e0134614.

Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
Melling N, Muth J, Simon R, Bokemeyer C, Terracciano L, Sauter G, Izbicki J, Marx A
DIAGN PATHOL. 2015;10:125.

Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization
Melling N, Simon R, Izbicki J, Terracciano L, Bokemeyer C, Sauter G, Marx A
AM J CLIN PATHOL. 2015;8(6):7009-15.

Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer
Melling N, Simon R, Mirlacher M, Izbicki J, Stahl P, Terracciano L, Bokemeyer C, Sauter G, Marx A
HISTOPATHOLOGY. 2015;68(2):191-8.

Salvage Completion Pancreatectomies as Damage Control for Post-pancreatic Surgery Complications: A Single-Center Retrospective Analysis
Nentwich M, El Gammal A, Lemcke T, Ghadban T, Bellon E, Melling N, Bachmann K, Reeh M, Uzunoglu F, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(6):1550-6.

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Reeh M, Harms-Effenberger K, Koenig A, Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu F, Vashist Y, Izbicki J, Pantel K, Bockhorn M
ANN SURG. 2015;261(6):1124-30.

Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
Reeh M, Nentwich M, Asani S, Uzunoglu F, Bockhorn M, Sauter G, Rösch T, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2015;19(4):587-93.

Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays
Stahl P, Schnellert J, Koop C, Simon R, Marx A, Izbicki J, Sauter G, Quaas A
PATHOL ONCOL RES. 2015;21(4):1183-9.

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki J, Bokemeyer C, Simon R, Sauter G, Marx A
BMC GASTROENTEROL. 2015;15(1):7.

Identification of HERC5 and its potential role in NSCLC progression
Wrage M, Hagmann W, Kemming D, Uzunoglu F, Riethdorf S, Harms-Effenberger K, Westphal M, Lamszus K, Kim S, Becker N, Izbicki J, Sandoval J, Esteller M, Pantel K, Risch A, Wikman-Kocher H
INT J CANCER. 2015;136(10):2264-72.

Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection
Anders M, Bähr C, El-Masry M, Marx A, Koch M, Seewald S, Schachschal G, Adler A, Soehendra N, Izbicki J, Neuhaus P, Pohl H, Rösch T
GUT. 2014;63(10):1535-1543.

Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett's esophagus
Anders M, Lucks Y, El-Masry M, Quaas A, Rösch T, Schachschal G, Bähr C, Gauger U, Sauter G, Izbicki J, Marx A
CLIN GASTROENTEROL H. 2014;12(3):405-10.

When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery
Asbun H, Conlon K, Fernandez-Cruz L, Riess H, Shrikhande S, Adham M, Bassi C, Bockhorn M, Büchler M, Charnley R, Dervenis C, Fingerhutt A, Gouma D, Hartwig W, Imrie C, Izbicki J, Lillemoe K, Milicevic M, Montorsi M, Neoptolemos J, Sandberg A, Sarr M, Vollmer C, Yeo C, Traverso L
SURGERY. 2014;155(5):887-892.

Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma
Atac A, Riecke B, Assaf A, Gröbe A, Friedrich R, Heiland M, Izbicki J, Kluwe L, Blessmann M
ANTICANCER RES. 2014;34(1):235-8.

Effects of hydroxyethyl starch and cell-free hemoglobin on microcirculation, tissue oxygenation, and survival in severe acute porcine pancreatitis: results of a randomized experimental trial
Bachmann K, Freitag M, Lohalm H, Tomkötter L, Dupree A, Koops S, Strate T, Izbicki J, Mann O
PANCREAS. 2014;43(6):855-62.

Beger and Frey Procedures for Treatment of Chronic Pancreatitis: Comparison of Outcomes at 16-Year Follow-Up
Bachmann K, Tomkoetter L, Erbes P, Hofmann B, Reeh M, Perez D, Vashist Y, Bockhorn M, Izbicki J, Mann O
J AM COLL SURGEONS. 2014;219(2):208-216.

Neuroendokrine Tumoren des Verdauungstrakts - Daten des deutschen NET-Registers
Begum N, Maasberg S, Plöckinger U, Anlauf M, Rinke A, Pöpperl G, Lehnert H, Izbicki J, Krausch M, Vashist Y, Raffel A, Bürk C, Hoffmann J, Goretzki P, Pape U
ZBL CHIR. 2014;139(3):276-83.

Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Bockhorn M, Uzunoglu F, Adham M, Imrie C, Milicevic M, Sandberg A, Asbun H, Bassi C, Büchler M, Charnley R, Conlon K, Cruz L, Dervenis C, Fingerhutt A, Friess H, Gouma D, Hartwig W, Lillemoe K, Montorsi M, Neoptolemos J, Shrikhande S, Takaori K, Traverso W, Vashist Y, Vollmer C, Yeo C, Izbicki J
SURGERY. 2014;155(6):977-988.

Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice
Burandt E, Schreiber M, Stein A, Minner S, Clauditz T, Bokemeyer C, Jänicke F, Fisch M, Izbicki J, Knecht R, Sauter G, Stahl P
GENE CHROMOSOME CANC. 2014;53(3):228-39.

Esophageal carcinoma cell line with high EGFR polysomy is responsive to gefitinib
Drenckhan A, Grob T, Dupree A, Dohrmann T, Mann O, Izbicki J, Gros S
LANGENBECK ARCH SURG. 2014;399(7):879-88.

Obesity research: Status quo and future outlooks
El Gammal A, Dupree A, Wolter S, Aberle J, Izbicki J, Güngör C, Mann O
World J of Transl Med. 2014;3(3):119-132.

The role of RANK-signaling in tumor cell proliferation and migration in pancreatic adenocarcinoma.
El Gammal A, Sander N, Aljonna F, Friedenberger H, Leonie K, Güngör C, Wolters-Eisfeld G, Hofmann B, Bockhorn M, Izbicki J, Perez D
2014. J Clin Oncol. suppl; abstr e15193.

Predictive Factors for Postoperative Pancreatic Fistula - Reply
Gebauer F, Izbicki J, Bockhorn M
ANN SURG. 2014;261(4):E99-E100.

Glomangioma of the lung: a case report and review of the literature
Gebauer F, Quaas A, Izbicki J, Vashist Y
J Med Case Rep. 2014;8(1):5.

Serum EpCAM expression in pancreatic cancer
Gebauer F, Struck L, Tachezy M, Vashist Y, Wicklein D, Schumacher U, Izbicki J, Bockhorn M
ANTICANCER RES. 2014;34(9):4741-4746.

Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer
Gebauer F, Wicklein D, Horst J, Sundermann P, Maar H, Streichert T, Tachezy M, Izbicki J, Bockhorn M, Schumacher U
PLOS ONE. 2014;9(11):e113023.

Chronische Pankreatitis
Ghadban T, Bachmann K, König A, Ittrich H, Groth S, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(3): 219-232.

Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors
Ghadban T, Perez D, Vashist Y, Bockhorn M, Koenig A, El Gammal A, Izbicki J, Metzger U, Hauswirth F, Frosina D, Jungbluth A
EJSO-EUR J SURG ONC. 2014;40(10):1307-1312.

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer
Ghadban T, Schmidt-Yang M, Uzunoglu F, Perez D, Tsui T, El Gammal A, Erbes P, Zilbermints V, Wellner U, Pantel K, Izbicki J, Vashist Y
J HUM GENET . 2014;59(12):661-666.

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
Grupp K, Boumesli R, Tsourlakis M, Koop C, Wilczak W, Adam M, Sauter G, Simon R, Izbicki J, Graefen M, Huland H, Steurer S, Schlomm T, Minner S, Quaas A
INT J CANCER. 2014;135(6):1399-1407.

High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
Grupp K, Habermann M, Sirma H, Simon R, Steurer S, Hube-Magg C, Prien K, Burkhardt L, Jedrzejewska K, Salomon G, Heinzer H, Wilczak W, Kluth M, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis M
MODERN PATHOL. 2014;27(1):96-106.

NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer
Grupp K, Ospina-Klinck D, Tsourlakis M, Koop C, Wilczak W, Adam M, Simon R, Sauter G, Izbicki J, Graefen M, Huland H, Steurer S, Schlomm T, Minner S, Quaas A
PROSTATE. 2014;74(10):1012-22.

High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions
Grupp K, Wilking J, Prien K, Hube-Magg C, Sirma H, Simon R, Steurer S, Budäus L, Haese A, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis M
EUR J CANCER. 2014;50(4):852-61.

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
Hanken H, Gaudin R, Gröbe A, Fraederich M, Eichhorn W, Smeets R, Simon R, Sauter G, Grupp K, Izbicki J, Sehner S, Heiland M, Blessmann M
J ORAL PATHOL MED. 2014;43(4):304-8.

Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)
Hartwig W, Vollmer C, Fingerhut A, Yeo C, Neoptolemos J, Adham M, Andrén-Sandberg A, Asbun H, Bassi C, Bockhorn M, Charnley R, Conlon K, Dervenis C, Fernandez-Cruz L, Friess H, Gouma D, Imrie C, Lillemoe K, Milićević M, Montorsi M, Shrikhande S, Vashist Y, Izbicki J, Büchler M
SURGERY. 2014;156(1):1-14.

ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer
Hofmann B, Stehr A, Dohrmann T, Güngör C, Herich L, Hiller J, Harder S, Ewald F, Gebauer F, Tachezy M, Precht C, Izbicki J, Bockhorn M, Wagener C, Wolters-Eisfeld G
CLIN CANCER RES. 2014;20(23):6117-26.

Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis
Hölscher A, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki J
EUR J CANCER. 2014;50(17):2950-7.

Multimodale Therapie des Ösophaguskarzinoms: Pro und Kontra
Hölscher A, Fetzner U, Uzunoglu F, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(3):199-214.

What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy
Kutup A, Nentwich M, Bollschweiler E, Bogoevski D, Izbicki J, Hölscher A
ANN SURG. 2014;260(6):1016-1022.

Expression of DIAPH1 is up-regulated in colorectal cancer and its down-regulation strongly reduces the metastatic capacity of colon carcinoma cells
Lin Y, Izbicki J, König A, Habermann J, Blechner C, Lange T, Schumacher U, Windhorst S
INT J CANCER. 2014;134(7):1571-82.

Zertifizierungen in der onkologischen Chirurgie: Bedeutung für die Wahl der Behandlungsstätte
Melling N, Drabik A, El Gammal A, Antonakis F, Darmann I, Izbicki J, Bockhorn M
CHIRURG. 2014;86(7):687-695.

Limits of surgery for pancreatic cancer
Nentwich M, König A, Izbicki J
Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti. 2014;93(9):445-449.

Pankreaskarzinome und periampulläre Karzinome
Nentwich M, König A, Izbicki J
Allgemein- und Viszeralchirurgie up2date. 2014;8(5):319-337.

Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus
Nentwich M, Loga K, Reeh M, Uzunoglu F, Marx A, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2014;18(2):242-9.

Molecular changes in pre-metastatic lymph nodes of esophageal cancer patients
Otto B, Koenig A, Tolstonog G, Jeschke A, Klätschke K, Vashist Y, Wicklein D, Wagener C, Izbicki J, Streichert T
PLOS ONE. 2014;9(7):e102552.

The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer
Rawnaq T, Dietrich L, Wolters-Eisfeld G, Uzunoglu F, Vashist Y, Bachmann K, Simon R, Izbicki J, Bockhorn M, Güngör C
MOL CANCER RES. 2014;12(5):670-80.

Rescue bedside laparotomy in the intensive care unit in patients too unstable for transport to the operating room
Schreiber J, Nierhaus A, Vettorazzi E, Braune S, Frings D, Vashist Y, Izbicki J, Kluge S
CRIT CARE. 2014;18(3):R123.

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)
Tachezy M, Gebauer F, Petersen C, Arnold D, Trepel M, Wegscheider K, Schafhausen P, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2014;14(1):411.

Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer
Tachezy M, Tiebel A, Gebauer F, Kutup A, Tharun L, Pantel K, Izbicki J, Vashist Y
HISTOPATHOLOGY. 2014;29(11):1467-1475.

Activated Leukocyte Cell Adhesion Molecule (CD166): An "Inert" Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki J, Bockhorn M
STEM CELLS. 2014;32(6):1429-1436.

Successful management of esophageal necrosis after endovascular repair of chronic type B aortic dissection
Tobisch A, Ittrich H, Izbicki J, Koenig A
ANN THORAC SURG. 2014;98(6):2209-2211.

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
Tol J, Gouma D, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun H, Bockhorn M, Büchler M, Conlon K, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki J, Lillemoe K, Milicevic M, Neoptolemos J, Shrikhande S, Vollmer C, Yeo C, Charnley R
SURGERY. 2014;156(3):591-600.

Loss of 4q21.23-22.1 is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
Uzunoglu F, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, Vashist Y, Reeh M, Sauter G, Simon R, Bockhorn M, Pantel K, Izbicki J, Wikman-Kocher H
PLOS ONE. 2014;9(12):e113315.

The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws?
Uzunoglu F, Koenig A, Izbicki J
EXPERT OPIN THER TAR. 2014;18(12):1421-6.

Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score
Uzunoglu F, Reeh M, Vettorazzi E, Ruschke T, Hannah P, Nentwich M, Vashist Y, Bogoevski D, König A, Janot M, Gavazzi F, Zerbi A, Todaro V, Malleo G, Uhl W, Montorsi M, Bassi C, Izbicki J, Bockhorn M
ANN SURG. 2014;260(5):857-64.

Single versus double Roux-en-Y reconstruction techniques in pancreaticoduodenectomy: a comparative single-center study
Uzunoglu F, Reeh M, Wollstein R, Melling N, Perez D, Vashist Y, Bogoevski D, Izbicki J, Bockhorn M
WORLD J SURG. 2014;38(12):3228-3234.

EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer
Vashist Y, Trump F, Gebauer F, Kutup A, Güngör C, Kalinin V, Muddasar R, Vettorazzi E, Yekebas E, Brandt B, Pantel K, Izbicki J
TARGET ONCOL. 2014;9(1):43-52.

Integrin expression in esophageal squamous cell carcinoma: loss of the physiological integrin expression pattern correlates with disease progression
Vay C, Hosch S, Stoecklein N, Klein C, Vallböhmer D, Link B, Yekebas E, Izbicki J, Knoefel W, Scheunemann P
PLOS ONE. 2014;9(11):e109026.

Individualized early goal-directed therapy in systemic Inflammation: is full utilization of preload reserve the optimal strategy?
Wodack K, Poppe A, Tomkötter L, Bachmann K, Strobel C, Bonk S, Havel J, Heckel K, Gocht A, Saugel B, Mann O, Izbicki J, Goetz A, Trepte C, Reuter D
CRIT CARE MED. 2014;42(12):e741-51.

Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.
Alsdorf W, Clauditz T, Hoenig T, Quaas A, Sirma H, Koenig A, Izbicki J, Sauter G, Marx A, Grob T
EXP MOL PATHOL. 2013;94(1):155-159.

PGK1 as predictor of CXCR4 expression, bone marrow metastases and survival in neuroblastoma
Ameis H, Drenckhan A, Loga K, Escherich G, Wenke K, Izbicki J, Reinshagen K, Gros S
PLOS ONE. 2013;8(12):e83701.

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting
Atanackovic D, Reinhard H, Meyer S, Spöck S, Grob T, Luetkens T, Yousef S, Cao Y, Hildebrandt Y, Templin J, Bartels K, Lajmi N, Stoiber H, Kröger N, Atz J, Seimetz D, Izbicki J, Bokemeyer C
HUM VACC IMMUNOTHER . 2013;9(12):2533-42.

Is the Whipple procedure harmful for long-term outcome in treatment of chronic pancreatitis? 15-years follow-up comparing the outcome after pylorus-preserving pancreatoduodenectomy and Frey procedure in chronic pancreatitis
Bachmann K, Tomkoetter L, Kutup A, Erbes P, Vashist Y, Mann O, Bockhorn M, Izbicki J
ANN SURG. 2013;258(5):815-20; discussion 820-1.

Effects of thoracic epidural anesthesia on survival and microcirculation in severe acute pancreatitis: a randomized experimental trial
Bachmann K, Trepte C, Tomkötter L, Hinsch A, Stork J, Bergmann W, Heidelmann L, Strate T, Goetz A, Reuter D, Izbicki J, Mann O
CRIT CARE. 2013;17(6):R281.

Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer
Bohn B, Mina S, Krohn A, Simon R, Kluth M, Harasimowicz S, Quaas A, Bockhorn M, Izbicki J, Sauter G, Marx A, Stahl P
HUM PATHOL. 2013;44(8):1524-33.

Gastropleural fistula in a patient with recurrent ovarian cancer receiving combination therapy with Carboplatin, gemcitabine, and bevacizumab
Dohrmann T, Kutup A, Mahner S, Müller V, Jänicke F, Izbicki J, Vashist Y
J CLIN ONCOL. 2013;31(12):e208-10.

Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
Drenckhan A, Kurschat N, Dohrmann T, Raabe N, Koenig A, Reichelt U, Kaifi J, Izbicki J, Gros S
J SURG RES. 2013;182(2):250-6.

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.
Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert A, Mauermann O, Izbicki J, Pantel K, Riethdorf S
CLIN CHEM. 2013;59(1):252-260.

Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice
Gebauer F, Wicklein D, Stübke K, Nehmann N, Schmidt A, Salamon J, Peldschus K, Nentwich M, Adam G, Tolstonog G, Bockhorn M, Izbicki J, Wagener C, Schumacher U
GUT. 2013;62(5):741-50.

Einfluss des zirkumferentiellen Resektionsrandes auf das Tumorrezidiv und Überleben beim pT3-Ösophaguskarzinom
Ghadban T, Vashist Y, Izbicki J, Kutup A
2013. DGAV-Posterbegehung: Ösophagus. .

Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer
Grob T, Hoenig T, Clauditz T, Atanackovic D, Koenig A, Vashist Y, Klose H, Simon R, Pantel K, Izbicki J, Bokemeyer C, Sauter G, Wilczak W
LUNG CANCER. 2013;79(3):221-7.

Correction: Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
Gros S, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Harms-Effenberger K, Reichelt U, Hoffmann R, Pantel K, Kaifi J, Izbicki J
PLOS ONE. 2013;8(5):.

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence
Grupp K, Diebel F, Sirma H, Simon R, Breitmeyer K, Steurer S, Hube-Magg C, Prien K, Pham T, Weigand P, Michl U, Heinzer H, Kluth M, Minner S, Tsourlakis M, Izbicki J, Sauter G, Schlomm T, Wilczak W
PROSTATE. 2013;73(15):1690-8.

Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
Grupp K, Höhne T, Prien K, Hube-Magg C, Tsourlakis M, Sirma H, Pham T, Heinzer H, Graefen M, Michl U, Simon R, Wilczak W, Izbicki J, Sauter G, Minner S, Schlomm T, Steurer S
EXP MOL PATHOL. 2013;95(2):227-34.

High mitochondria content is associated with prostate cancer disease progression
Grupp K, Jedrzejewska K, Tsourlakis M, Koop C, Wilczak W, Adam M, Quaas A, Sauter G, Simon R, Izbicki J, Graefen M, Huland H, Schlomm T, Minner S, Steurer S
MOL CANCER. 2013;12(1):145.

Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.
Grupp K, Kohl S, Sirma H, Simon R, Steurer S, Becker A, Adam M, Izbicki J, Sauter G, Minner S, Schlomm T, Tsourlakis M
MODERN PATHOL. 2013;26(5):733-742.

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
Grupp K, Sanader S, Sirma H, Simon R, Koop C, Prien K, Hube-Magg C, Salomon G, Graefen M, Heinzer H, Minner S, Izbicki J, Sauter G, Schlomm T, Tsourlakis M
MOL ONCOL. 2013;7(6):1001-11.

Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor).
Izbicki J, Tsui T, Bohn B, Bockhorn M
J GASTROINTEST SURG. 2013;17(3):581-585.

Stapled hemorrhoidopexy versus Milligan-Morgan hemorrhoidectomy in circumferential third-degree hemorrhoids: long-term results of a randomized controlled trial
Kim J, Vashist Y, Thieltges S, Zehler O, Gawad K, Yekebas E, Izbicki J, Kutup A
J GASTROINTEST SURG. 2013;17(7):1292-8.

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
Kluth M, Hesse J, Heinl A, Krohn A, Steurer S, Sirma H, Simon R, Mayer P, Schumacher U, Grupp K, Izbicki J, Pantel K, Dikomey E, Korbel J, Plass C, Sauter G, Schlomm T, Minner S
MODERN PATHOL. 2013;26(7):975-83.

Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma
König A, Reeh M, Dancau A, Rathjens M, Gros S, Uzunoglu F, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki J
ANTICANCER RES. 2013;33(11):4975-82.

Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer
Nentwich M, Bohn B, Uzunoglu F, Reeh M, Quaas A, Grob T, Perez D, Kutup A, Bockhorn M, Izbicki J, Vashist Y
J THORAC CARDIOV SUR. 2013;146(4):781-7.

Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis
Reeh M, Bockhorn M, Görgens D, Vieth M, Hoffmann T, Simon R, Izbicki J, Sauter G, Schumacher U, Anders M
BRIT J CANCER. 2013;109(7):1848-58.

S3-Leitlinie zum exokrinen Pankreaskarzinom
Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geissler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E
Z GASTROENTEROL. 2013;51(12):1395-440.

CXCR7 expression in esophageal cancer
Tachezy M, Zander H, Gebauer F, Loga K, Pantel K, Izbicki J, Bockhorn M
J TRANSL MED. 2013;11:238.

The impact of early goal-directed fluid management on survival in an experimental model of severe acute pancreatitis
Trepte C, Bachmann K, Stork J, Friedheim T, Hinsch A, Goepfert M, Mann O, Izbicki J, Goetz A, Reuter D
INTENS CARE MED. 2013;39(4):717-26.

LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.
Uzunoglu F, Bockhorn M, Fink J, Reeh M, Vettorazzi E, Gawad K, Bogoevski D, Vashist Y, Tsui T, Koenig A, Mann O, Izbicki J
J GASTROINTEST SURG. 2013;17(3):494-500.

The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.
Uzunoglu F, Heumann A, Musici S, Kutup A, König A, Roch N, Thomssen A, Dohrmann T, Tsui T, Mann O, Izbicki J, Vashist Y
LUNG CANCER. 2013;79(2):151-155.

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma
Uzunoglu F, Kolbe J, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, König A, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN ONCOL. 2013;24(5):1282-90.

Surgery of esophageal cancer
Uzunoglu F, Reeh M, Kutup A, Izbicki J
LANGENBECK ARCH SURG. 2013;398(2):189-93.

C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC
Uzunoglu F, Yavari N, Bohn B, Nentwich M, Reeh M, Pantel K, Perez D, Tsui T, Bockhorn M, Mann O, Izbicki J, Wikman H, Vashist Y
LUNG CANCER. 2013;81(1):123-9.

Surgery in chronic pancreatitis.
Bachmann K, Mann O, Izbicki J
G Chir. 2012;33(1-2):5-9.

Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumors
Blessmann M, Gröbe A, Quaas A, Kaifi J, Mistakidis G, Bernreuther C, Sauter G, Gros S, Rawnaq T, Friedrich R, Mautner V, Smeets R, Heiland M, Schachner M, Izbicki J
ORAL SURG ORAL MED ORAL PATHOL ORAL RADIOL. 2012;113(2):239-44.

Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.
Deutsch L, Wrage M, Koops S, Glatzel M, Uzunoglu F, Kutup A, Hinsch A, Sauter G, Izbicki J, Pantel K, Wikman H
GENE CHROMOSOME CANC. 2012;51(6):618-629.

[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)].
Digestive C, Diseases M, Hoffmeister A, Mayerle J, Beglinger C, Büchler M, Bufler P, Dathe K, Fölsch U, Izbicki J, Izbicki J, Kahl S, Klar E, Keller J, Knoefel W, Layer P, Loehr M, Meier R, Riemann J, Rünzi M, Schmid R, Schreyer A, Tribl B, Werner J, Witt H, Mössner J, Lerch M
Z GASTROENTEROL. 2012;50(11):1176-1224.

Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula
Gebauer F, Kloth K, Tachezy M, Vashist Y, Cataldegirmen G, Izbicki J, Bockhorn M, Bockhorn M
ANN SURG. 2012;256(1):130-8.

Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung.
Grob T, Kannengiesser I, Tsourlakis M, Atanackovic D, König A, Vashist Y, Klose H, Marx A, Koops S, Simon R, Izbicki J, Bokemeyer C, Sauter G, Wilczak W
MODERN PATHOL. 2012;25(12):1566-1573.

CXCR4/SDF-1α-mediated chemotaxis in an in vivo model of metastatic esophageal carcinoma.
Gros S, Graeff H, Drenckhan A, Kurschat N, Blessmann M, Rawnaq T, Izbicki J
IN VIVO. 2012;26(4):711-718.

Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer.
Gros S, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Harms-Effenberger K, Reichelt U, Hoffman R, Pantel K, Kaifi J, Izbicki J
PLOS ONE. 2012;7(10):47287.

Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival.
Harms-Effenberger K, Schröder C, Zu Eulenburg C, Reeh M, Tachezy M, Riethdorf S, Vashist Y, Izbicki J, Pantel K, Bockhorn M
INT J CANCER. 2012;131(4):475-483.

Pupil evaluation in addition to Glasgow Coma Scale components in prediction of traumatic brain injury and mortality.
Hoffmann M, Lefering R, Rueger J, Kolb J, Izbicki J, Rücker A, Rupprecht M, Lehmann W, Surgery T
Br J Surg. 2012;99 Suppl 1:122-130.

[Acetylsalicylic acid protects against solid tumors].
Izbicki J, Hofmann B, Nitschmann S
INTERNIST. 2012;53(2):232-234.

[Emergency interventions for perforation and bleeding in esophageal cancer patients].
König A, Hofmann B, Groth S, Izbicki J
CHIRURG. 2012;83(8):719, 722-725.

Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.
König A, Reeh M, Burdelski C, Wengert C, Gawad K, Izbicki J, Bockhorn M
LANGENBECK ARCH SURG. 2012;397(8):1251-1259.

The role of circumferential resection margin in esophageal cancer: Does it influence local recurrence and survival?
Kutup A, Ghadban T, Vashist Y, Bogoevski D, Izbicki J
J CLIN ONCOL. 2012;30(4_suppl):23.

Endoscopic ultrasound staging in gastric cancer: Does it help management decisions in the era of neoadjuvant treatment?
Kutup A, Vashist Y, Groth S, Vettorazzi E, Yekebas E, Soehendra N, Izbicki J
ENDOSCOPY. 2012;44(6):572-6.

Endoscopic ultrasound staging in gastric cancer: Does it help management decisions in the era of neoadjuvant treatment?
Kutup A, Vashist Y, Groth S, Vettorazzi E, Yekebas E, Soehendra N, Izbicki J
ENDOSCOPY. 2012;44(6):572-576.

Losses at chromosome 4q are associated with poor survival in operable ductal pancreatic adenocarcinoma.
Lübke A, Baudis M, Matthaei H, Vashist Y, Verde P, Hosch S, Erbersdobler A, Klein C, Izbicki J, Knoefel W, Stoecklein N
PANCREATOLOGY. 2012;12(1):16-22.

PTEN deletion is rare but often homogeneous in gastric cancer.
Mina S, Bohn B, Simon R, Krohn A, Reeh M, Arnold D, Bokemeyer C, Sauter G, Izbicki J, Marx A, Stahl P
J CLIN PATHOL. 2012;65(8):693-698.

High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Minner S, Lübke A, Kluth M, Bokemeyer C, Jänicke F, Izbicki J, Schlomm T, Sauter G, Wilczak W
HISTOPATHOLOGY. 2012;61(3):445-453.

High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers
Minner S, Luebke A, Kluth M, Bokemeyer C, Jänicke F, Izbicki J, Schlomm T, Sauter G, Wilczak W
HISTOPATHOLOGY. 2012;61(3):445-53.

Surgery for advanced and metastatic pancreatic cancer--current state and trends
Nentwich M, Bockhorn M, König A, Izbicki J, Cataldegirmen G
ANTICANCER RES. 2012;32(5):1999-2002.

L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.
Rawnaq T, Quaas A, Zander H, Gros S, Reichelt U, Blessmann M, Wilczak W, Schachner M, Sauter G, Izbicki J, Kaifi J
J SURG RES. 2012;173(2):314-319.

Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction
Reeh M, Mina S, Bockhorn M, Kutup A, Nentwich M, Marx A, Sauter G, Rösch T, Izbicki J, Bogoevski D
Br J Surg. 2012;99(10):1406-14.

An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma.
Reeh M, Nentwich M, von Loga K, Schade J, Uzunoglu F, König A, Bockhorn M, Rösch T, Izbicki J, Bogoevski D
ANN THORAC SURG. 2012;93(3):890-896.

Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors.
Roth C, Stückrath I, Pantel K, Izbicki J, Tachezy M, Schwarzenbach H
PLOS ONE. 2012;7(6):38248.

VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma
Schultze A, Ben Batalla I, Riethdorf S, Bubenheim M, Yekebas E, Erbersdobler A, Reichelt U, Effenberger K, Schmidt T, Izbicki J, Bokemeyer C, Pantel K, Fiedler W, Loges S
CLIN EXP METASTAS. 2012;29(8):879-87.

VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Schultze A, Ben-Batalla I, Riethdorf S, Bubenheim M, Yekebas E, Erbersdobler A, Reichelt U, Harms-Effenberger K, Schmidt T, Izbicki J, Bokemeyer C, Pantel K, Fiedler W, Loges S
CLIN EXP METASTAS. 2012;29(8):879-887.

Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.
Stahl P, Kilgué A, Tennstedt P, Minner S, Krohn A, Simon R, Krause G, Izbicki J, Graefen M, Sauter G, Schlomm T, Wilczak W
PROSTATE. 2012;72(8):898-903.

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
Tachezy M, Harms-Effenberger K, Zander H, Minner S, Gebauer F, Vashist Y, Sauter G, Pantel K, Izbicki J, Bockhorn M
INT J CANCER. 2012;131(2):396-405.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients
Tachezy M, Zander H, Gebauer F, Marx A, Kaifi J, Izbicki J, Bockhorn M
J SURG RES. 2012;177(1):e15-20.

ALCAM (CD166) expression and serum levels in pancreatic cancer
Tachezy M, Zander H, Marx A, Stahl P, Gebauer F, Izbicki J, Bockhorn M
PLOS ONE. 2012;7(6):e39018.

Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu F, Kaufmann C, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, Pantel K, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN SURG ONCOL. 2012;19(7):2159-2168.

Notfallsternotomie bei perkutaner zentralvenöser Punktion - ein Fallbericht
Uzunoglu F, Koenig A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-3.

[Emergency sternotomy during percutaneous central venous catheterisation - a case report].
Uzunoglu F, König A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-263.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, Koenig A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-9; discussion 679-80.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study.
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, König A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-680.

Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
Vashist Y, Harms-Effenberger K, Vettorazzi E, Riethdorf S, Yekebas E, Izbicki J, Pantel K
ANN SURG. 2012;255(6):1105-1112.

Management of the difficult duodenal stump in penetrating duodenal ulcer disease: a comparative analysis of duodenojejunostomy with "classical" stump closure (Nissen-Bsteh).
Vashist Y, Yekebas E, Gebauer F, Tachezy M, Bachmann K, König A, Kutup A, Izbicki J
LANGENBECK ARCH SURG. 2012;397(8):1243-1249.

Chronic pancreatitis: modern surgical management.
Bachmann K, Izbicki J, Yekebas E
LANGENBECK ARCH SURG. 2011;396(2):139-149.

Impact of early or delayed elective resection in complicated diverticulitis.
Bachmann K, Krause G, Rawnaq T, Tomkötter L, Vashist Y, Shahmiri S, Izbicki J, Bockhorn M
WORLD J GASTROENTERO. 2011;17(48):5274-5279.

Is Toupet fundoplication the procedure of choice for treating gastroesophageal reflux disease? Results of a prospective randomized experimental trial comparing three major antireflux operations in a porcine model.
Bachmann K, Wachowiak R, Rempf C, Vashist Y, Mann O, Yekebas E, Izbicki J, Gawad K
SURG ENDOSC. 2011;25(10):3235-3244.

Arterial en bloc resection for pancreatic carcinoma.
Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas E, Izbicki J
Br J Surg. 2011;98(1):86-92.

Chronic pancreatitis complicated by cavernous transformation of the portal vein: contraindication to surgery?
Bockhorn M, Gebauer F, Bogoevski D, Molmenti E, Cataldegirmen G, Vashist Y, Yekebas E, Izbicki J, Mann O
SURGERY. 2011;149(3):321-8.

Chronic pancreatitis complicated by cavernous transformation of the portal vein: contraindication to surgery?
Bockhorn M, Gebauer F, Bogoevski D, Molmenti E, Cataldegirmen G, Vashist Y, Yekebas E, Izbicki J, Mann O
SURGERY. 2011;149(3):321-328.

How radical should surgery be for early esophageal cancer?
Bogoevski D, Bockhorn M, König A, Reeh M, von Loga K, Sauter G, Rösch T, Izbicki J
WORLD J SURG. 2011;35(6):1311-1320.

Multivisceral resections in pancreatic cancer: identification of risk factors
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-63.

Multivisceral resections in pancreatic cancer: identification of risk factors.
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-2763.

Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F, Tachezy M, Harms-Effenberger K, von Loga K, Zander H, Marx A, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG ONCOL. 2011;104(2):140-145.

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.
Güngör C, Zander H, Harms-Effenberger K, Vashist Y, Kalinina T, Izbicki J, Yekebas E, Bockhorn M
CANCER RES. 2011;71(14):5009-5019.

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].
Moehler M, Al-Batran S, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer W, Dietrich C, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert H, Galle P, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann J, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz R, Höfler H, Höhler T, Hölscher A, Horneber M, Hübner J, Izbicki J, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause B, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer H, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag P, Schmid R, Schmidberger H, Schmiegel W, Schmoll H, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C, AWMF [
Z GASTROENTEROL. 2011;49(4):461-531.

Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors.
Rawnaq T, Kunkel M, Bachmann K, Simon R, Zander H, Brandl S, Sauter G, Izbicki J, Kaifi J
ANN SURG ONCOL. 2011;18(2):559-565.

Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.
Rawnaq T, Schwarzenbach H, Schurr P, Freise K, Brandl S, Izbicki J, Kaifi J
J SURG RES. 2011;169(1):31-35.

High surgical morbidity following distal pancreatectomy: still an unsolved problem.
Reeh M, Nentwich M, Bogoevski D, König A, Gebauer F, Tachezy M, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(5):1110-1117.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
J GASTROINTEST SURG. 2011;15(5):829-35.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
J GASTROINTEST SURG. 2011;15(5):829-835.

ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M, Zander H, Marx A, Gebauer F, Rawnaq T, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG RES. 2011;170(2):226-232.

The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist Y, Kutup A, Musici S, Yekebas E, Mina S, Uzunoglu F, Zehler O, König A, Cataldegirmen G, Bockhorn M, Harms-Effenberger K, Kalinin V, Pantel K, Izbicki J
CELL ONCOL. 2011;34(4):281-288.

Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer.
Vashist Y, Loos J, Dedow J, Tachezy M, Uzunoglu F, Kutup A, Yekebas E, Izbicki J
ANN SURG ONCOL. 2011;18(4):1130-1138.

Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
Vashist Y, Uzunoglu F, Deutsch L, Kalinin V, Zehler O, Alzadjali A, Kutup A, Izbicki J, Yekebas E
J SURG RES. 2011;166(2):121-127.

Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.
Vashist Y, Uzunoglu F, Kutup A, Gebauer F, König A, Deutsch L, Zehler O, Busch P, Kalinin V, Izbicki J, Yekebas E
J SURG ONCOL. 2011;104(3):305-311.

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G, Bockhorn M, Schachner M, Izbicki J, Kaifi J
BMC CANCER. 2011;11:1-7.

Surgical treatment in chronic pancreatitis timing and type of procedure.
Bachmann K, Kutup A, Mann O, Yekebas E, Izbicki J
BEST PRACT RES CL GA. 2010;24(3):299-310.

Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.
Choschzick M, Lassen P, Lebeau A, Marx A, Terracciano L, Heilenkötter U, Jänicke F, Bokemeyer C, Izbicki J, Sauter G, Simon R
MODERN PATHOL. 2010;23(4):603-610.

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
El Gammal A, Brüchmann M, Zustin J, Isbarn H, Hellwinkel O, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf T, Izbicki J, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T
CLIN CANCER RES. 2010;16(1):56-64.

Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model.
Gros S, Dohrmann T, Peldschus K, Schurr P, Kaifi J, Kalinina T, Reichelt U, Mann O, Strate T, Adam G, Hoffman R, Izbicki J
INT J CANCER. 2010;126(11):2671-2681.

Orthotopic fluorescent peritoneal carcinomatosis model of esophageal cancer.
Gros S, Dohrmann T, Rawnaq T, Kurschat N, Bouvet M, Wessels J, Hoffmann R, Izbicki J, Kaifi J
ANTICANCER RES. 2010;30(10):3933-3938.

Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma.
Gros S, Kurschat N, Dohrmann T, Reichelt U, Dancau A, Peldschus K, Adam G, Hoffman R, Izbicki J, Kaifi J
MOL CANCER THER. 2010;9(7):2037-2045.

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T, Bockhorn M, Kaifi J, Thieltges S, Güngör C, Harms-Effenberger K, Strelow A, Reichelt U, Sauter G, Pantel K, Izbicki J, Yekebas E
INT J CANCER. 2010;127(8):1931-1940.

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Murga-Penas E, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Harms-Effenberger K, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2010;10:295.

[Timing and concepts of surgical treatment of upper gastrointestinal haemorrhage].
König A, Gawad K, Yekebas E, Seewald S, Izbicki J
ZBL CHIR. 2010;135(1):65-69.

Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Kutup A, Yekebas E, Izbicki J
Recent Results Cancer Res. 2010;182:115-125.

19q13 amplification is associated with high grade and stage in pancreatic cancer.
Kuuselo R, Simon R, Karhu R, Tennstedt P, Marx A, Izbicki J, Yekebas E, Sauter G, Kallioniemi A
GENE CHROMOSOME CANC. 2010;49(6):569-575.

Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.
Marx A, Burandt E, Choschzick M, Simon R, Yekebas E, Kaifi J, Mirlacher M, Atanackovic D, Bokemeyer C, Fiedler W, Terracciano L, Sauter G, Izbicki J
HUM PATHOL. 2010;41(11):1577-1585.

Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
Marx A, Zielinski M, Kowitz C, Dancau A, Thieltges S, Simon R, Choschzick M, Yekebas E, Kaifi J, Mirlacher M, Atanackovic D, Brümmendorf T, Fiedler W, Bokemeyer C, Izbicki J, Sauter G
HISTOPATHOLOGY. 2010;57(3):418-426.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Neoptolemos J, Stocken D, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore M, Gallinger S, Mariette C, Wente M, Izbicki J, Friess H, Lerch M, Dervenis C, Oláh A, Butturini G, Doi R, Lind P, Smith D, Valle J, Palmer D, Buckels J, Thompson J, McKay C, Rawcliffe C, Büchler M
JAMA-J AM MED ASSOC. 2010;304(10):1073-1081.

Coexpression of MAGE-A peptides and HLA class I molecules in hepatocellular carcinoma.
Roch N, Kutup A, Vashist Y, Yekebas E, Kalinin V, Izbicki J
ANTICANCER RES. 2010;30(5):1617-1623.

Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS).
Shukla P, Barreto S, Fingerhut A, Bassi C, Büchler M, Dervenis C, Gouma D, Izbicki J, Neoptolemos J, Padbury R, Sarr M, Traverso W, Yeo C, Wente M
SURGERY. 2010;147(1):144-153.

Omental infarction in the postpartum period: a case report and a review of the literature.
Tachezy M, Grotelüschen R, Gebauer F, Marx A, Izbicki J, Kaifi J
J Med Case Rep. 2010;4:368.

Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M, Reichelt U, Melenberg T, Gebauer F, Izbicki J, Kaifi J
HISTOL HISTOPATHOL. 2010;25(10):1239-1246.

Y-box-binding protein-1 is a potential novel tumour marker for neuroblastoma.
Wachowiak R, Thieltges S, Rawnaq T, Kaifi J, Fiegel H, Metzger R, Quaas A, Mertens P, Till H, Izbicki J
ANTICANCER RES. 2010;30(4):1239-1242.

Quo vadis STARR?: A prospective long-term follow-up of stapled transanal rectal resection for obstructed defecation syndrome
Zehler O, Vashist Y, Bogoevski D, Bockhorn M, Yekebas E, Izbicki J, Kutup A, Bockhorn M
J GASTROINTEST SURG. 2010;14(9):1349-54.

Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement.
Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Schurr P, Busch C, Thayssen G, Izbicki J, Strate T
SURGERY. 2009;145(4):392-398.

Polymorphism Arg290Arg in esophageal-cancer-related gene 1 (ECRG1) is a prognostic factor for survival in esophageal cancer.
Bachmann K, Shahmiri S, Kaifi J, Schurr P, Mann O, Rawnaq T, Block S, Kalinin V, Izbicki J, Strate T
J GASTROINTEST SURG. 2009;13(2):181-187.

Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.
Bachmann K, Standl N, Kaifi J, Busch P, Winkler E, Mann O, Izbicki J, Strate T
SURG ENDOSC. 2009;23(7):1587-1593.

Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
Blessmann M, Pohlenz P, Atac A, Kaifi J, Zu Eulenburg C, Kalinin V, Merkert P, Smeets R, Heiland M, Blake F, Schmelzle R, Izbicki J
INT J ORAL MAX SURG. 2009;38(7):779-784.

Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability
Bockhorn M, Cataldegirmen G, Kutup A, Marx A, Burdelski C, Vashist J, Mann O, Liebl L, König A, Izbicki J, Yekebas E
ANN SURG ONCOL. 2009;16(5):1212-21.

Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.
Bockhorn M, Cataldegirmen G, Kutup A, Marx A, Burdelski C, Vashist Y, Mann O, Deutsch L, König A, Izbicki J, Yekebas E
ANN SURG ONCOL. 2009;16(5):1212-1221.

[Operative technique and outcome in metabolic surgery: conventional and banded gastric bypass]
Busch P, Wolter S, Rawnaq T, Kaifi J, Aberle J, Izbicki J, Mann O
ZBL CHIR. 2009;134(1):32-37.

Extended central pancreatic resection as an alternative for extended left or extended right resection for appropriate pancreatic neoplasms.
Cataldegirmen G, Schneider C, Bogoevski D, König A, Kaifi J, Bockhorn M, Deutsch L, Vashist Y, Izbicki J, Yekebas E
SURGERY. 2009.

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
Gnjatic S, Cao Y, Reichelt U, Yekebas E, Nölker C, Marx A, Erbersdobler A, Nishikawa H, Hildebrandt Y, Bartels K, Horn C, Stahl T, Gout I, Filonenko V, Ling K, Cerundolo V, Luetkens T, Ritter G, Friedrichs K, Leuwer R, Hegewisch-Becker S, Izbicki J, Bokemeyer C, Old L, Atanackovic D
INT J CANCER. 2009.

Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
Hoffmann A, Kaifi J, Vallböhmer D, Yekebas E, Grimminger P, Leers J, Izbicki J, Hölscher A, Schneider P, Metzger R, Brabender J
J SURG ONCOL. 2009;100(5):414-417.

The role of vascular adhesion molecules PECAM-1 (CD 31), VCAM-1 (CD 106), E-selectin (CD62E) and P-selectin (CD62P) in severe porcine pancreatitis.
Kleinhans H, Kaifi J, Mann O, Reinknecht F, Freitag M, Hansen B, Schurr P, Izbicki J, Strate T
HISTOL HISTOPATHOL. 2009;24(5):551-557.

Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - a rare tumor with uncertain malignant behaviour: a case report
Koenig A, Quaas A, Ries T, Yekebas E, Gawad K, Vashist Y, Burdelski C, Mann O, Izbicki J, Erbersdobler A
J Med Case Rep. 2009;3:62.

Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma.
König A, Prenzel K, Bogoevski D, Yekebas E, Bubenheim M, Faithova L, Vashist Y, Gawad K, Baldus S, Pantel K, Schneider P, Hölscher A, Izbicki J
ANN SURG ONCOL. 2009;16(2):454-462.

Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - a rare tumor with uncertain malignant behaviour: a case report.
König A, Quaas A, Ries T, Yekebas E, Gawad K, Vashist Y, Burdelski C, Mann O, Izbicki J, Erbersdobler A
J Med Case Rep. 2009;3:62.

For which type of chronic pancreatitis is the "Hamburg procedure" indicated?
Kutup A, Vashist Y, Kaifi J, Yekebas E, Izbicki J
J HEPATO-BILIARY-PAN. 2009.

Therapeutic small-volume resuscitation preserves pancreatic microcirculation in acute experimental pancreatitis of graded severity in rats.
Mann O, Kaifi J, Blöchle C, Schneider C, Yekebas E, Kluth D, Izbicki J, Strate T
PANCREATOLOGY. 2009;9(5):652-661.

Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Mann O, Tiefenbacher W, Kaifi J, Schneider C, Kluth D, Blöchle C, Yekebas E, Izbicki J, Strate T
PANCREAS. 2009;38(1):58-64.

HER-2 amplification is highly homogenous in gastric cancer.
Marx A, Tharun L, Muth J, Dancau A, Simon R, Yekebas E, Kaifi J, Mirlacher M, Brümmendorf T, Bokemeyer C, Izbicki J, Sauter G
HUM PATHOL. 2009;40(6):769-777.

Combined alpha-methylacyl coenzyme A racemase/p53 analysis to identify dysplasia in inflammatory bowel disease.
Marx A, Wandrey T, Simon P, Wewer A, Grob T, Reichelt U, Minner S, Simon R, Spehlmann M, Tigges W, Soehendra N, Seitz U, Seewald S, Izbicki J, Yekebas E, Kaifi J, Mirlacher M, Terracciano L, Fleischmann A, Raedler A, Sauter G
HUM PATHOL. 2009;40(2):166-173.

Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.
Rawnaq T, Kleinhans H, Uto M, Schurr P, Reichelt U, Cataldegirmen G, Gawad K, Yekebas E, Schachner M, Izbicki J, Kaifi J
ANTICANCER RES. 2009;29(4):1195-1199.

[Lateral anastomosis techniques: Partington-Rochelle and V-shaped excision]
Schneider C, Cataldegirmen G, Mann O, Yekebas E, Izbicki J
CHIRURG. 2009;80(1):28-33.

Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients
Schurr P, Kohrs D, Reichelt U, Kaifi J, Vashist Y, Bachmann K, Bogoevski D, Yekebas E, Izbicki J
DIGEST SURG. 2009;26(3):229-35.

Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.
Schurr P, Kohrs D, Reichelt U, Kaifi J, Vashist Y, Bachmann K, Bogoevski D, Yekebas E, Izbicki J
DIGEST SURG. 2009;26(3):229-235.

Clinical Value of Loss of Heterozygosity in Serum Microsatellite DNA of Patients With Gastrointestinal Stromal Tumors.
Schurr P, Oikonomou D, Kaifi J, Merkert P, Wolter S, Kleinhans H, Reichelt U, Mann O, Gawad K, Strate T, Yekebas E, Izbicki J
J CLIN GASTROENTEROL. 2009;43(1):27-35.

Abscess of adrenal gland caused by disseminated subacute Nocardia farcinica pneumonia. A case report and mini-review of the literature.
Tachezy M, Simon P, Ilchmann C, Vashist Y, Izbicki J, Gawad K
BMC INFECT DIS. 2009;9:194.

Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M, Ruosaari S, Eijk P, Kaifi J, Hollmén J, Yekebas E, Izbicki J, Brakenhoff R, Streichert T, Riethdorf S, Glatzel M, Ylstra B, Pantel K, Wikman H
CLIN CANCER RES. 2009;15(5):1566-1574.

HER-2/neu analysis in breast cancer bone metastases.
Zustin J, Boddin K, Tsourlakis M, Burandt E, Mirlacher M, Jänicke F, Izbicki J, Rüther W, Rueger J, Bokemeyer C, Simon R, Sauter G
J CLIN PATHOL. 2009;62(6):542-546.

Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients.
Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Busch C, Thayssen G, Izbicki J, Strate T
SURG ENDOSC. 2008;22(11):2470-2477.

[A new cholecystectomy with no visible scarring and low risk. A possible alternative to natural orifice transluminal endoscopic surgery]
Bachmann K, Izbicki J, Strate T
CHIRURG. 2008.

Chronic pancreatitis--a surgeons' view.
Bachmann K, Mann O, Izbicki J, Strate T
MED SCI MONITOR. 2008;14(11):198-205.

Yield and safety of bedside open lung biopsy in mechanically ventilated patients with acute lung injury or acute respiratory distress syndrome.
Baumann H, Kluge S, Balke L, Yekebas E, Izbicki J, Amthor M, Kreymann K, Meyer A
SURGERY. 2008;143(3):426-433.

Short tandem repeat polymorphism in exon 4 of esophageal cancer related gene 2 predicts relapse of oral squamous cell carcinoma.
Blessmann M, Kaifi J, Schurr P, Cihan A, Kalinin V, Trump F, Atac A, Heiland M, Pohlenz P, Blake F, Schmelzle R, Izbicki J
ORAL ONCOL. 2008;44(2):143-147.

Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
Bogoevski D, Chayeb H, Cataldegirmen G, Schurr P, Kaifi J, Mann O, Yekebas E, Izbicki J
J GASTROINTEST SURG. 2008;12(11):1830-1838.

Is it time for a new TNM classification in esophageal carcinoma?
Bogoevski D, Onken F, König A, Kaifi J, Schurr P, Sauter G, Izbicki J, Yekebas E
ANN SURG. 2008;247(4):633-641.

Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.
Bogoevski D, Strate T, Yekebas E, Izbicki J
LANGENBECK ARCH SURG. 2008;393(6):911-917.

Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens [, Ten K, Obertop H, Izbicki J, Lanschot v
DIS ESOPHAGUS. 2008;21(6):488-495.

Late morbidity after duodenum-preserving pancreatic head resection with bile duct reinsertion into the resection cavity.
Cataldegirmen G, Bogoevski D, Mann O, Kaifi J, Izbicki J, Yekebas E
Br J Surg. 2008;95(4):447-452.

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.
Fiegel H, Kaifi J, Quaas A, Varol E, Krickhahn A, Metzger R, Sauter G, Till H, Izbicki J, Erttmann R, Kluth D
PEDIATR SURG INT. 2008;24(1):101-105.

Midkine is highly expressed in neuroblastoma tissues.
Fiegel H, Kaifi J, Wachowiak R, Quaas A, Aridome K, Ichihara-Tanaka K, Muramatsu T, Metzger R, Izbicki J, Erttmann R, Kluth D, Till H
PEDIATR SURG INT. 2008;24(12):1355-1359.

A legend leaves (but not quite, we hope): Nib Soehendra.
Izbicki J, Rösch T
ENDOSCOPY. 2008;40(12):973.

Anal angina--pelvic sepsis and streptococcal toxic shock syndrome after rectoscopy and mucosal biopsy.
Kastl S, Horstkotte M, Schäfer H, Izbicki J, Scherpe S, Nierhaus A
INT J COLORECTAL DIS. 2008;23(2):225-226.

Bihiläre Lymphome bei nichtseminomatösem Keimzelltumor
Mann O, Kleinhans H, Gebauer F, Kaifi J, Schurr P, Izbicki J, Strate T
CHIRURG. 2008;79(9):874-6.

[Intrathoracic lesions in association with germ cell tumor of the testis]
Mann O, Kleinhans H, Gebauer F, Kaifi J, Schurr P, Izbicki J, Strate T
CHIRURG. 2008;79(9):874-876.

AMACR expression in colorectal cancer is associated with left-sided tumor localization.
Marx A, Simon P, Simon R, Mirlacher M, Izbicki J, Yekebas E, Kaifi J, Terracciano L, Sauter G
VIRCHOWS ARCH. 2008;453(3):243-248.

Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience.
Schurr P, Lentz E, Block S, Kaifi J, Kleinhans H, Cataldegirmen G, Kutup A, Schneider C, Strate T, Yekebas E, Izbicki J
J GASTROINTEST SURG. 2008;12(7):1232-1238.

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.
Stoecklein N, Hosch S, Bezler M, Stern F, Hartmann C, Vay C, Siegmund A, Scheunemann P, Schurr P, Knoefel W, Verde Pablo E, Reichelt U, Erbersdobler A, Grau R, Ullrich A, Izbicki J, Klein C
CANCER CELL. 2008;13(5):441-453.

Resection vs drainage in treatment of chronic pancreatitis: long-term results of a randomized trial.
Strate T, Bachmann K, Busch P, Mann O, Schneider C, Bruhn J, Yekebas E, Kuechler T, Blöchle C, Izbicki J
GASTROENTEROLOGY. 2008;134(5):1406-1411.

Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist Y, Blessmann M, Trump F, Kalinin V, Kutup A, Schneider C, Gawad K, Kaifi J, Schmelzle R, Izbicki J, Yekebas E
J ORAL PATHOL MED. 2008;37(8):480-484.

Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
Wachowiak R, Rawnaq T, Metzger R, Quaas A, Fiegel H, Kähler N, Rolle U, Izbicki J, Kaifi J, Till H
PEDIATR SURG INT. 2008;24(12):1361-1364.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients
Yekebas E, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist Y, Schurr P, Liebl L, Thieltges S, Gawad K, Schneider C, Izbicki J
ANN SURG. 2008;247(2):300-9.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas E, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist Y, Schurr P, Liebl L, Thieltges S, Gawad K, Schneider C, Izbicki J
ANN SURG. 2008;247(2):300-309.

Focal progression in patients with gastrointestinal stromal tumors after initial response to imatinib mesylate: a three-center-based study of 38 patients.
Al-Batran S, Hartmann J, Heidel F, Stoehlmacher J, Wardelmann E, Dechow C, Düx M, Izbicki J, Kraus T, Fischer T, Jäger E
GASTRIC CANCER. 2007;10(3):145-152.

P53 is an independent prognostic factor for survival in thyroid cancer.
Bachmann K, Pawliska D, Kaifi J, Schurr P, Schwoerer J, Mann O, Kahl H, Izbicki J, Strate T
ANTICANCER RES. 2007;27(6):3993-3997.

Laparoscopic gastric tailoring for huge subcardial gastrointestinal stromal tumor.
Bogoevski D, Mann O, Schurr P, Izbicki J, Strate T
JSLS-J SOC LAPAROEND. 2007;11(3):394-397.

Value of repeat resection for survival in pulmonary metastases from soft tissue sarcoma.
Deutsch L, Elson F, Quaas A, Gawad K, Izbicki J
ANTICANCER RES. 2007;27(4):2897-2902.

Ileoanal-pouch reconstruction does not impair sphincter function or quality of life.
Gawad K, Wenske S, von Schrenck T, Izbicki J
HEPATO-GASTROENTEROL. 2007;54(77):1477-1482.

New insights in surgical pancreatology.
Izbicki J
HPB : the official journal of the International Hepato Pancreato Biliary Association. 2007;9(2):90-91.

Management of acute cholecystitis and the surgeon's dilemma: the gun shoots both directions.
Izbicki J, Strate T
ENDOSCOPY. 2007;39(4):359-360.

Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis.
Kaifi J, Cataldegirmen G, Wachowiak R, Schurr P, Kleinhans H, Kosti G, Yekebas E, Mann O, Kutup A, Kalinin V, Strate T, Izbicki J
ANTICANCER RES. 2007;27(1):69-73.

Midkine as a prognostic marker for gastrointestinal stromal tumors.
Kaifi J, Fiegel H, Rafnsdottir S, Aridome K, Schurr P, Reichelt U, Wachowiak R, Kleinhans H, Yekebas E, Mann O, Ichihara-Tanaka K, Muramatsu T, Kluth D, Strate T, Izbicki J
J CANCER RES CLIN. 2007;133(7):431-435.

Short tandem repeat polymorphism in exon 4 of esophageal cancer-related gene 2 detected in genomic DNA is a prognostic marker for esophageal cancer.
Kaifi J, Rawnaq T, Schurr P, Yekebas E, Mann O, Merkert P, Link B, Kalinin V, Pantel K, Sauter G, Strate T, Izbicki J
AM J SURG. 2007;194(3):380-384.

L1 is associated with micrometastatic spread and poor outcome in colorectal cancer.
Kaifi J, Reichelt U, Quaas A, Schurr P, Wachowiak R, Yekebas E, Strate T, Schneider C, Pantel K, Schachner M, Sauter G, Izbicki J
MODERN PATHOL. 2007;20(11):1183-1190.

Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer.
Kutup A, Link B, Schurr P, Strate T, Kaifi J, Bubenheim M, Seewald S, Yekebas E, Soehendra N, Izbicki J
ENDOSCOPY. 2007;39(8):715-719.

Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.
Link B, Reichelt U, Schreiber M, Kaifi J, Wachowiak R, Bogoevski D, Bubenheim M, Cataldegirmen G, Gawad K, Issa R, Koops S, Izbicki J, Yekebas E
ANN SURG ONCOL. 2007;14(9):2591-2599.

Percutaneous transhepatic cholangiodrainage as rescue therapy for symptomatic biliary leakage without biliary tract dilation after major surgery.
Link B, Yekebas E, Bogoevski D, Kutup A, Adam G, Izbicki J, Krupski G
J GASTROINTEST SURG. 2007;11(2):166-170.

Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, Yekebas E, Schuch G, Izbicki J, Pantel K, Bokemeyer C, Fiedler W
CLIN CANCER RES. 2007;13(1):76-80.

Thy-1 as a potential novel diagnostic marker for gastrointestinal stromal tumors.
Oikonomou D, Hassan K, Kaifi J, Fiegel H, Schurr P, Reichelt U, Aridome K, Yekebas E, Mann O, Kluth D, Strate T, Izbicki J
J CANCER RES CLIN. 2007;133(12):951-955.

Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel K, König A, Schneider P, Schnickmann C, Baldus S, Schröder W, Bollschweiler E, Dienes H, Mueller R, Izbicki J, Hölscher A
ANN SURG ONCOL. 2007;14(2):954-959.

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus.
Reichelt U, Duesedau P, Tsourlakis M, Quaas A, Link B, Schurr P, Kaifi J, Gros S, Yekebas E, Marx A, Simon R, Izbicki J, Sauter G
MODERN PATHOL. 2007;20(1):120-129.

Central mesenteric lymph node BER-Ep4+ cells in colorectal cancer: challenge to sentinel node concept?
Schurr P, Behnke S, Kaifi J, Bogoevski D, Link B, Mann O, Strate T, Pantel K, Izbicki J, Yekebas E
DIGEST SURG. 2007;24(1):19-27.

Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience.
Schurr P, Strate T, Rese K, Kaifi J, Reichelt U, Petri S, Kleinhans H, Yekebas E, Izbicki J
ANN SURG. 2007;245(2):273-281.

[Arterio-venous aneurysm of splenic vessels--a rare differential diagnosis for cardio-circulatory symptoms]
Strate T, Mann O, König A, Bachmann K, Izbicki J
ZBL CHIR. 2007;132(1):77-80.

L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
Wachowiak R, Fiegel H, Kaifi J, Quaas A, Krickhahn A, Schurr P, Erttmann R, Schachner M, Kluth D, Sauter G, Izbicki J
ANN SURG ONCOL. 2007;14(12):3575-3580.

Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis.
Wachowiak R, Kaifi J, Schurr P, Merkert P, Yekebas E, Schwarzenbach H, Strate T, Sauter G, Izbicki J
ANTICANCER RES. 2007;27(1):477-481.

Microsatellite analysis in serum DNA as a diagnostic tool for distinction of patients with unknown pancreatic masses.
Wachowiak R, Kaifi J, Schwarzenbach H, Yekebas E, Merkert P, Schurr P, Hansen B, Reichelt U, Strate T, Pantel K, Izbicki J
DIAGN MOL PATHOL. 2007;16(3):174-178.

Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS).
Wente M, Bassi C, Dervenis C, Fingerhut A, Gouma D, Izbicki J, Neoptolemos J, Padbury R, Sarr M, Traverso L, Yeo C, Büchler M
SURGERY. 2007;142(5):761-768.

Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition.
Wente M, Veit J, Bassi C, Dervenis C, Fingerhut A, Gouma D, Izbicki J, Neoptolemos J, Padbury R, Sarr M, Yeo C, Büchler M
SURGERY. 2007;142(1):20-25.

Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections.
Yekebas E, Wolfram L, Cataldegirmen G, Habermann C, Bogoevski D, König A, Kaifi J, Schurr P, Bubenheim M, Nolte-Ernsting C, Adam G, Izbicki J
ANN SURG. 2007;246(2):269-280.

Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy.
Yekebas E, Bogoevski D, Bubenheim M, Link B, Kaifi J, Wachowiak R, Mann O, Kutup A, Cataldegirmen G, Wolfram L, Erbersdobler A, Klein C, Pantel K, Izbicki J
WORLD J GASTROENTERO. 2006;12(40):6515-6521.

Biological and molecular characterization of a new human ampullary cancer cell line
Peiper M, Alldinger I, Heller R, Pilarsky C, Schumacher U, Knoefel W, Heinecke A, Izbicki J
ANTICANCER RES. 2003;23(1A):291-8.

Letzte Aktualisierung aus dem FIS: 18.10.2019 - 05:28 Uhr